Treatment of Survivors After Botulism Outbreak

This study has been completed.
Sponsor:
Collaborator:
Rajavithi Biomolecular Research Center
Information provided by:
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT00314080
First received: March 30, 2006
Last updated: October 23, 2008
Last verified: August 2007
  Purpose

Background. Northern Thailand's biggest botulism outbreak to date occurred on 14 March 2006 and affected 209 people. Of these, 42 developed respiratory failure, and 25 of those who developed respiratory failure were referred to 9 high facility hospitals for treatment of severe respiratory failure and autonomic nervous system involvement. Among these patients, we aimed to assess the relationship between the rate of ventilator dependence and the occurrence of treatment by day 4 versus day 6 after exposure to bamboo shoots (the source of the botulism outbreak), as well as the relationship between ventilator dependence and negative inspiratory pressure.

Methods. The investigators reviewed the circumstances and timing of symptoms following exposure. Mobile teams treated patients with botulinum antitoxin on day 4 or day 6 after exposure in Nan Hospital (Nan, Thailand). Eighteen patients (in 7 high facility hospitals) with severe respiratory failure received a low- and high-rate repetitive nerve stimulation test, and negative inspiratory pressure was measured.


Condition Intervention
Respiratory Failure
Botulism
Drug: Botulinum AntiToxin
Procedure: neuro-electrophysiologic study, repetitive nerve stimulation
Procedure: Protocol early weaning ventilator after recovery of repetitive nerve stimulation and stable negative inspiratory pressure

Study Type: Observational
Official Title: An Outbreak of Botulism in Thailand: Clinical Manifestations and Management of Severe Respiratory Failure

Resource links provided by NLM:


Further study details as provided by Rajavithi Hospital:

Estimated Enrollment: 18
Study Start Date: March 2006
Estimated Study Completion Date: April 2006
  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusions:

  • Ate the bamboo shoots in Banluang district, on March,14 2006
  • Clinical of respiratory failure and need ventilator assistant
  • Needed to referred to other hospital
  • The staffs of referred hospital willing to participate in the Thai Botulism study group

Exclusion Criteria:

  • Patients who did not eat bamboo shoots in Banluang district on March14,2006.
  • No clinical of respiratory failure.
  • Not referred to other hospital.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314080

Locations
Thailand
Rajavithi Hospital
Bangkok, Thailand, 10400
Sponsors and Collaborators
Rajavithi Hospital
Rajavithi Biomolecular Research Center
Investigators
Principal Investigator: Subsai Kongsaengdao, M.D. Rajavithi Hospital
  More Information

Additional Information:
Pubmed  This link exits the ClinicalTrials.gov site

Publications:
Agarwal AK, Goel A, Kohli AFood-borne botulism. J Assoc Physicians India. 2004 Aug;52:677-8.

ClinicalTrials.gov Identifier: NCT00314080     History of Changes
Other Study ID Numbers: RVH_CER_001
Study First Received: March 30, 2006
Last Updated: October 23, 2008
Health Authority: Thailand: Ministry of Public Health

Keywords provided by Rajavithi Hospital:
Botulism
Botulinum anti-toxin
Repetitive nerve stimulation
Respiratory failure

Additional relevant MeSH terms:
Botulism
Respiratory Insufficiency
Bacterial Infections
Chemically-Induced Disorders
Clostridium Infections
Foodborne Diseases
Gram-Positive Bacterial Infections
Nervous System Diseases
Neuromuscular Diseases
Neuromuscular Junction Diseases
Neurotoxicity Syndromes
Poisoning
Respiration Disorders
Respiratory Tract Diseases
Botulinum Antitoxin
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on October 21, 2014